Puma Biotechnology Inc (NASDAQ: PBYI) popped 88 percent Monday on news that its neratinib candidate, an early-stage breast cancer treatment for human epidermal growth factor receptor-2 (HER2) positive mutations, was advancing in the U.S. Food and ...
Boy with just days to find £500000 for vital cancer treatment
A family is in a painful race against time to raise £500,000 for their sick son with a rare cancer. Dawson Wilcock, who is 19 months old, was diagnosed with heptoblastoma, a rare liver cancer, and is currently being treated at Queen's Medical Centre, ...
No comments:
Post a Comment